Library / Laws / 117th Congress / House Bills / H.R. 2891
H.R. 2891
To prohibit prescription drug companies from compensating other prescription drug companies to delay the entry of a generic drug, biosimilar biological product, or interchangeable biological product into the market.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2021-04-28 | 20.4K | ⠃⠗⠋ |